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Exhaled and nasal NO (ENO, NNO) have been suggested as markers for inflammation in lower and upper
respiratory tract respectively. It is still unknown how a number of factors, apart from airway inflammation, can
influence NO levels. The aim of this study was to determine the effect of a nitrate-rich meal on ENO and NNO.
Sixteen healthy subjects were observed during 1 week on normal diet before a nitrate-restricted diet was
introduced in the next. On day 3 of the second week they were made to ingest a nitrate rich meal. ENO, NNO,
plasma nitrate and plasma L-arginine were followed before the meal and afterwards for 3 h.
ENO and NNO as well as plasma nitrate and plasma L-arginine were significantly elevated after the nitrate-rich
meal. The median maximal increase of ENO and NNO was 47% and 13% respectively. We found a moderate but
significant correlation between the rise in plasma nitrate and ENO (rs¼0?57, P¼0?027) but none between plasma
nitrate and NNO (rs¼70?02, P¼0?95).
As nitrate in the diet seems to substantially influence the levels of ENO it is important either to restrict or register
the intake of nitrate-rich food prior to measuring ENO.
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Nitric oxide in exhaled air (ENO) has been suggested as a
marker for airway inflammation (1,2), mainly on the basis
of the observation that steroid-naive asthmatic patients
have high levels of ENO, which readily decreases to normal
levels after steroid treatment (3). If so, measurements of
ENO would offer a fast, easy and non-invasive procedure
for instantaneous detection of airway inflammation, at least
in steroid-naive non-smoking patients.
ENO seems to be representative for NO produced in the
airways (4). NO in blood entering alveolar space binds very
quickly to haem, and will only contribute in a minor way to
the exhaled NO levels.
Although the knowledge of nasal NO (NNO) still is
limited, NNO has been suggested as a marker for nasalReceived 13 October 2000 and accepted 8 November 2000.
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0954-6111/01/020153+06 $35?00/0inflammation, having been shown to increase in patients
with allergic rhinitis (5, 6) and during upper respiratory
tract infections (7). In the upper airways, very high levels of
nitric oxide are produced in the paranasal sinuses (8).
However, the increased NO levels found in patients with
allergic rhinitis are believed to originate mainly in the nasal
mucosa (6).
The method of choice for measurement of ENO has
been developed over the past few years. In 1997 an
European Respiratory Society (ERS) task force (9)
published guidelines for the performance of measure-
ments, and recently guidelines for the standardization have
been published by the American Thoracic Society (ATS)
(10). Knowledge of a number of factors, for instance diet,
which could influence the ENO levels, is however still
lacking.
Nitric oxide is formed enzymatically from L-arginine in
the presence of NO synthase, which exists in at least three
different isoforms. Nitric oxide is moreover also formed
non-enzymatically, in the oral cavity (11) and in the gastric
ventricle (12), by reduction of nitrite ðNOÿ2 Þ, a reaction
which is enhanced by an acidic environment. NO might,# 2001 HARCOURT PUBLISHERS LTD
TABLE 1. Basic data on the subjects
Females (n=7) Males (n=9)
Age (years) 27 25
VC (% pred) 101 100
FEV1 (% pred) 101 102
Weight (kg) 54 79
Phadiatop* 0/7 1/9
*0=negative, 1=positive.
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as proposed by Nagase et al. (13).
Although it is well known that the intake of food with a
high nitrate ðNOÿ3 Þ content to a large extent influences
blood nitrate levels, it is not clear how variations in plasma
nitrate influence the exhaled NO levels.
In the gut, the nitrate in the diet is absorbed into
the blood and actively transported to the saliva by
the salivary glands (14). In the oral cavity it is converted
to nitrite by bacteria, mainly in the deep clefts on the rear
part of the tongue. The balance that exist between NO
and nitrite is regulated by the pH, i.e. the more
acidic environment the more NO will be formed. Salivary
nitrate and nitrite have been shown to increase
with increasing doses of ingested nitrate (15), although
there has been shown to be a wide inter-
individual variability of conversion of nitrate to nitrite
(16). Zetterquist et al. (17) have investigated the effect of an
intake of 400 mg potassium nitrate solution on ENO levels,
which they found to increase by a maximum of 150% 2h
after the ingestion. Concomitantly, they found an increase
of nitrite in saliva following the pattern of its increase in
plasma. Mouthwash with an anti-bacterial agent reduced
NO release by almost 50%. They did not find any increase
in nasal NO.
Studies have not been made of the way L-arginine
in the diet can influence exhaled or nasal NO levels. After
intake of L-arginine capsules in a dose of 0?05 g kg71, no
increase of exhaled NO was shown among asthmatic
patients (18), but Kharitonov et al. (19) found an increase
in healthy subjects after ingestion of 0?1 g L-arginine kg71.
Nasal NO has been shown to increase after infusion of L-
arginine (20).
The aim of the present study was to investigate whether
the intake of a nitrate-rich meal would influence ENO and
NNO levels. We analysed ENO and NNO after a normal
diet, a nitrate-restricted diet and after intake of a nitrate-
rich meal in 16 healthy volunteers. The levels of plasma
nitrate and plasma L-arginine levels were simultaneously
recorded.
Subjects and methods
SUBJECTS
Twenty healthy (10 males/10 females), non-smoking
volunteers with no history of obstructive lung disease
or respiratory tract infection during the previous 3 weeks
were recruited for the study. Three females had
to be excluded because of an infection of the respiratory
tract caught during the study period as did one male
subject who developed symptoms of allergic rhinitis. ENO
and NNO as well as plasma nitrate and plasma L-arginine
levels were measured in 16 subjects. All subjects passed
an examination including spirometry (21) and a Phadia-
topTM test (22). Basic data on the subjects are presented in
Table 1.The local committee of ethics approved the study and
informed consent was obtained from all volunteers prior to
their inclusion in the study.
EXHALED AND NASAL NO
Exhaled NO was measured during a slow single-exhalation
for 20 sec against an oral pressure of 5 cm H2O at a
constant flow rate of 50ml sec71, in accordance with ATS
recommendations (10). The measurements were performed
in triplicate at each occasion and the mean NO concentra-
tion (ppb) and mean output (nlmin71) during the plateau
phase (12–18 sec of the exhalation) were registered. Nasal
NO was measured by letting the analyser sample nasal air
directly from one nostril at a constant sample rate of
8ml sec71, while the subject held their breath for 20 sec and
closed the velum voluntarily. The nasal NO concentration
during the plateau phase was registered. One measurement
was performed in each nostril and the mean NO
concentration was calculated.
A chemiluminescence analyser was used to measure nitric
oxide, (CLD 700 AL; Ecophysics, Du¨rnten, Switzerland). A
special computerized biofeedback system was used to
regulate exhalation flow rate (Aerocrine NO SystemTM,
Aerocrine AB, Stockholm, Sweden). A two-point calibra-
tion of the analyser was performed daily with a certified NO
calibration gas. The exhaled NO output, i.e. ENO
elimination rate [NO concentration (ppb ¼ nl l71)6flow
rate (lmin71)] is presented because these values are more
accurate, the NO concentration being strongly influenced
by small changes in the exhalation flow. To make
comparisons possible with other studies where only NO
concentrations are presented, the individual concentrations
of exhaled NO are also presented. The intra-individual
variability expressed as coecient of variation (CV) for
ENO, NNO and plasma nitrate were estimated through
measurements taken on 3 days at a normal diet, with an int-
erval of at least 2 days between each, on all included subjects.
NITRATE
Nitrate in plasma was analysed by the gas chromatography/
mass spectrometry (GC/MS) method described by Tesch et
al. (23) and further developed by Wennmalm et al. (24).
FIG. 1. (A) Change in exhaled NO, mean+SEM. (B)
Change in nasal NO, mean+SEM. (C) Change in plasma
nitrate, mean+SEM. (D) Change in plasma L-arginine,
mean+SEM.
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L-arginine was measured with a fully automatic ion-
exchange-chromatography system, as previously described
(25).
DIET
During the first week the subjects were kept on normal diet
without any restrictions. During week 2 a low-nitrate diet
was introduced (26), but with a normal L-arginine content.
After 48 h of a low-nitrate diet the subjects were given a
meal rich in nitrate: 100 g lettuce, 75 g spinach, 100 g
ham, 75 g cucumber, three to five potatoes and a tomato.
The nitrate content was equivalent to 1 g nitrate, and the L-
arginine content to 1?4 g. ENO and NNO and plasma
nitrate were then analysed every 15 min for 3 h and
thereafter daily for 2 days. Plasma L-arginine was analysed
before the meal and hourly during the first 3 h afterwards.
The nitrate rich meal was served at 09.00 hours for half
of the subjects and for the other half at 12.00 hours in a
randomized way. The ENO and NNO measurements taken
on days of normal diet, and on the days following the
nitrate-rich meal, were performed at the same time of the
day as on the meal was served.
LEAN BODY MASS (LBM)
The increase in plasma nitrate and plasma L-arginine was
considered to be dependent on plasma volume. A lean body
mass index has been calculated for each individual as this is
the best available index for plasma volume (27). The lean
body mass index has been used in analysing the correlation
between the changes in ENO, NNO, plasma nitrate and
plasma L-arginine.
STATISTICS
Statistical analyses were carried out with SAS, version 6.12
(SAS Statistical package, Cary, NC, U.S.A.). The
results have been given as medians of change in ENO
output (nlmin71), NNO concentration (ppb), nitrate
concentration (mmol l71) and L-arginine concentration
(mmol l71) in plasma, unless otherwise stated. The indivi-
dual changes from baseline (i.e. the value before the meal
was served) of exhaled and nasal NO, plasma nitrate
and plasma L-arginine after the nitrate-rich meal were
calculated as [value at respectively time point]7 [baseline
value]. For each individual the maximal change from
baseline in ENO concentration was also noted. Significance
testing was based on Student’s t-test using logarithm-
transformed values. The area under the curve (AUC),
representing the total increase from baseline during the
follow-up period, was calculated for each parameter. Since
the observations were equally spaced in time, the mean
change for each parameter can be used, representing the
area under the curve (28). As this method does not allow for
any missing values, the mean of the two adjacent values has
been used to represent the missing value.Spearman’s rank correlation coecient (rs) have been
calculated to analyse any correlation between both maximal
and total change in ENO/NNO and nitrate/L-arginine.
Results
We found significant increases of ENO and NNO, plasma
nitrate and plasma L-arginine after intake of the nitrate-rich
meal [see Fig. 1(A–D) (mean + SEM)]. The individual NO
concentrations before the nitrate-rich meal, the maximal
increase of exhaled NO, irrespective of time-point (range 15
min–2 h 45 min), and the levels 3 h after the meal are
presented in Fig. 2. The median of maximal ENO increase
after the meal was 47% (range 7–89%) and the median of
maximal NNO increase was 13% (range 0?1–36%).
The maximal increase in ENO and plasma nitrate
occurred 2 h after the meal and subsequently decreased,
although both ENO and nitrate were found to be
significantly elevated throughout the measurement period.
L-arginine was only examined before the meal and 1, 2 and
3 h afterwards. Here, too, the maximal increase occurred 2 h
after the meal.
FIG. 2. Maximal change in exhaled NO concentration
(ppb).
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plasma L-arginine would depend on the subjects’ plasma
volume. As all the subjects were given the same amount of
food, the intake of nitrate and L-arginine in relation to
plasma volume differed markedly. We had chosen to use
lean body mass (LBM) as an index for plasma volume. We
found an inverse correlation between maximal increase in
ENO and LBM, (rs¼70?78, P¼0?0003) and between
maximal increase in plasma nitrate and LBM (rs¼70?78,
P¼ 0?0006). The maximal rise in plasma L-arginine was not
dependent on LBM (rs¼70?0044, P¼0?98). The maximal
increase in NNO did not correlate to LBM (rs¼ 0?11,
P¼0?68).
As a measure of the total change of ENO, NNO, plasma
nitrate and plasma L-arginine the area under the curve
(AUC) for each factor was calculated, and used in the
subsequent analysis. We found a significant correlation
between the total change of ENO and plasma nitrate
(rs¼0?57, P¼0?027), but no significant correlation between
ENO and plasma L-arginine (rs¼0?19, P¼0?47). NNO was
not significantly correlated with change of either plasma
nitrate (rs¼70?018, P¼0?95) or plasma L-arginine
(rs¼70?094, P¼0?73).
We did not find any significant change of ENO or NNO
when the subjects were kept on a nitrate-restricted as
compared with a normal diet (median 35?1 vs. 34?6
nlmin71 and 587 vs. 534 ppb respectively). In contrast,
the plasma nitrate levels were significantly lower with a
nitrate-restricted diet (median 36?9 vs. 45?6 mmol l71,
P50?02). For these analyses we compared the median of
three measurements on different occasions during week 1
with the median value before the meal on day 3 of the
second week.
The intra-individual coecient of variation (CV), for
repeated measurements on three occasions at least 2 daysapart, when the subjects were on normal diet, was 19% for
ENO, 9% for NNO and 22% for plasma nitrate.
Discussion
Both ENO and NNO were significantly increased after the
intake of a meal rich in nitrate. The increase in ENO was
dose-dependent, i.e. the subjects with the highest dose per
LBM (an index for plasma volume) showed the greatest
increase.
The median increase of ENO for all subjects was 43%
occurring 2 h after the meal. These findings are in
agreement with Zetterquist et al., reporting a maximal
increase of ENO 2h after ingestion of 400 mg potassium
nitrate solution. However the ENO increase was very much
lower (43%) after intake of nitrate-rich food intake
compared with the intake of potassium nitrate solution
(150%), even though the total nitrate content of the meal
was higher than the nitrate content of the solution. One
possible explanation may be the different bio-availability of
the nitrate in food and in potassium nitrate solution,
enabling the latter to be more rapidly and completely
absorbed than the nitrate in the food.
Contrary to Zetterquist et al., we found an increase of
NNO. One explanation for this might be that the meal also
contained L-arginine. The production of NNO may be
limited by the availability of the substrate L-arginine (20).
The L-arginine content of the meal, due to its content in the
ham, was equivalent to 1?4 g L-arginine; we also found a
significant increase of plasma L-arginine after the meal.
Lundberg et al. (20) have shown that an L-arginine infusion
of 16 mg per kg body weight, increases NNO from 420 ppb
to 475 ppb (13%) as against the ingestion of 15 mg L-
arginine per kg body weight in this study, also resulting in
increased NNO by 13%.
Nevertheless, we found no significant decreases of either
ENO or NNO after 3 days with a nitrate-restricted diet.
The plasma nitrate levels were, however, significantly lower
with a nitrate-restricted diet.
This might indicate that the plasma nitrate levels are less
important than the other factors determining ENO levels,
at least when there are only minor changes of plasma
nitrate. The median decrease in plasma nitrate, on a nitrate-
restricted diet, was 5?9 mmol l71 compared with the median
maximal increase of 81?5 mmol l71 after the nitrate-rich
meal. Alternatively, since ENO is influenced by salivary
nitrate/nitrite concentrations (18) the result may indicate
that nitrate uptake in the salivary glands is biologically
resulted to keep a minimum of nitrate in the saliva for host
defence purposes (12).
One limitation of the study is that the diet also contained
L-arginine, which makes it dicult to separate the effects of
increased plasma nitrate from that of L-arginine, at the
ENO and NNO levels. The time courses for the increases of
nitrate and L-arginine were also similar. However, in
previous investigations the ingestion of L-arginine in
amounts equivalent to the contents in the nitrate-rich meal,
has not been shown to induce any increase in ENO levels in
normal subjects (19).
NO IN EXHALED AIR AFTER A NITRATE-RICH MEAL 157The area under the curve (AUC) was used as an index of
the total change of ENO, NNO, plasma nitrate and L-
arginine during the follow-up period of 3 h. Although one
could speculate that changes of plasma nitrate and plasma
L-arginine would precede the changes in ENO and NNO,
the kinetics for these processes are not known, making for
ambiguity in any analysis based on lag-time.
Another limitation of the study is that we did not
compare the changes in ENO after a nitrate-rich meal with
variations in ENO during a normal day. There has been
contradicting data concerning diurnal variation of ENO.
Ten Hacken et al. (29) have not been able to demonstrate
any such variation in asthmatic patients with nocturnal
asthma. On the other hand Massaro et al. (30) have
presented an abstract indicating great diurnal variation,
although with a maximal increase of ENO between 04.00
hours and 08.00 hours and a maximal decrease at 20.00
hours in healthy individuals. In our study half of the
subjects had their meal at 09.00 hours and the other half at
noon. If there were a diurnal variation of ENO in the
pattern suggested by Massaro et al., the ENO values would
tend to decrease during the morning hours when we
followed half of the group, as well as among the subjects
receiving their meal at noon.
The ENO levels in our study started to return to baseline
within 3 h, indicating that the changes were related to the
food intake and not to diurnal variation.
The finding that ENO could increase up to 89% after a
nitrate-rich meal, indicates that it is important to register or
cease the intake of nitrate-rich food the same day as ENO
measurements take place. Although a normal diet rarely
consists of, for example, 100 g of salad and 75 g spinach, the
effect on ENO might be substantial even with lower nitrate
contents in recently ingested food.
How long subjects should refrain from nitrate-rich food
may vary according to the need for accuracy and this will
also have to be considered in relation to other sources of
measurement errors. We followed the ENO levels 3 h after
the meal, and at that time-point half of the subjects still had
higher ENO levels than before the meal.
It seems, however, of no value to introduce a nitrate
restricted diet for a longer period of time in order to avoid
dietary influences on ENO levels.
Another way of reducing the influence of exogenous
nitrate on ENO levels might be to reduce the nitrate
reducing bacteria in the oral cavity and/or increase the pH
on the oral cavity before the measurements are performed.
Before making any such recommendations further studies
are called for.
In conclusion we found that ENO increases significantly
after ingestion of a nitrate-rich meal. It seems therefore
important to restrict the intake of food rich in nitrate prior
to measuring nitric oxide
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